MedTrace Logo

PIBD-SETQuality: the Inception Cohort and Safety Registry

NCT03571373 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2026-08-11

No results posted yet for this study

Summary

The purpose of this study is to analyse effectiveness and safety signals of current treatment strategies in routine practice for patients with pediatric-onset inflammatory bowel disease (PIBD) and to correlate this to their individual risk factors.

Conditions

Interventions

OTHER

No intervention

No intervention due to the observational set-up of this study.

Sponsors & Collaborators

Principal Investigators

  • Lissy de Ridder, Professor, MD · Erasmus Medical Center

  • Nicholas Croft, Professor, MD · Barts and the London School of Medicine, Queen Mary University of London

  • Frank Ruemmele, Professor, MD · Hopital Necker-Enfants Malades, Paris

Eligibility

Min Age
0 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-03
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03571373 on ClinicalTrials.gov